INVESTIGATOR AGREEMENT PAGEInvestigator Agreement • November 28th, 2022
Contract Type FiledNovember 28th, 2022Protocol Title: A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects with Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma